Company news: Johnson & Johnson’s (JNJ) quarterly results beat analysts’ forecasts

Johnson & Johnson (JNJ) reported Q2 FY2025 earnings of $2.77 per share (versus $2.82 per share in Q2 FY2024), beating analysts’ consensus estimate of $2.68 per share.

The company’s quarterly revenues amounted to $23.743 bln (+5.8% y/y), beating analysts’ consensus estimate of $22.854 bln.

The company also issued upside guidance for FY2025, seeing EPS of $10.80-10.90 versus analysts’ consensus estimate of $10.64 and its prior guidance of $10.50-10.70 and revenues of $93.2-93.6 bln versus analysts’ consensus estimate of $91.42 bln and its prior guidance of $91.0-91.4 bln.

JNJ rose to $157.00 (+1.18%) in pre-market trading.